Indian domestic pharma market is estimated at Rs 90,400 crore ending FY15: IBEF
Data shows M&A activity increases by 44.5 per cent in India; the country is expected to take 25 per cent of biosimilars market…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
India Brand Equity Foundation
Happy of government’s proactive support: GVK BIO CEO
Commerce secy could take matter to WTO In what is probably the first instance of its kind, the Department of Commerce has decided…